The Advanced Kidney Cancer Center of Excellence from UroToday and GU OncToday delivers disease, treatment and guidelines information in this rapidly changing area. This series of articles explores ongoing clinical trials, including trials looking at biomarkers and genomic data, in addition to live conference coverage that will provide real-time perspectives from Dr Sumanta Kumar Pal and colleagues.

Read more online in UroToday here